Explore

Trendline Trendline
Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair

Atisama Therapeutics Advances RB042 in Phase 1 Trial, Appoints New Board Chair
Trendline Trendline
Biogen Advances Alzheimer's Drug Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Despite Phase 2 Trial Setback

Biogen Advances Alzheimer's Drug Despite Phase 2 Trial Setback
Trendline Trendline
Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements

Nanoviricides Reports Third Quarter Loss Amid Clinical Advancements
Trendline Trendline
Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development

Fosun Pharma and AriBio Sign Agreement for Alzheimer's Drug Development
Trendline Trendline
BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates

BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates

BridgeBio's Attruby Shows Potential Superiority Over Pfizer's Tafamidis in ATTR-CM Survival Rates
Trendline Trendline
Palatin Technologies Advances Obesity Treatments with MC4R Agonists

Palatin Technologies Advances Obesity Treatments with MC4R Agonists

Palatin Technologies Advances Obesity Treatments with MC4R Agonists
Trendline Trendline
Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer

Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer

Atossa Therapeutics Hosts Event on (Z)-Endoxifen for ER-Positive Breast Cancer
Trendline Trendline
AstraZeneca's Hypoparathyroidism Drug Faces Efficacy Questions Amid Rivalry

AstraZeneca's Hypoparathyroidism Drug Faces Efficacy Questions Amid Rivalry

AstraZeneca's Hypoparathyroidism Drug Faces Efficacy Questions Amid Rivalry
Trendline Trendline
Fosun Pharma and AriBio Partner for Alzheimer's Drug Development

Fosun Pharma and AriBio Partner for Alzheimer's Drug Development

Fosun Pharma and AriBio Partner for Alzheimer's Drug Development
Trendline Trendline
IQVIA and Kexing Biopharm Collaborate to Enhance Global Biosimilar Development with AI

IQVIA and Kexing Biopharm Collaborate to Enhance Global Biosimilar Development with AI

IQVIA and Kexing Biopharm Collaborate to Enhance Global Biosimilar Development with AI
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion

Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion

Perspective Therapeutics Advances VMT-α-NET with High Response Rates and Manufacturing Expansion
Trendline Trendline
Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials

Perspective Therapeutics Advances VMT-α-NET with High Efficacy in Clinical Trials